SUBSYS
Peakfentanyl
NDASUBLINGUALSPRAY
Approved
Jan 2012
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20
Clinical Trials (5)
A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors
Started Sep 2025
100 enrolled
Cancer
Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP
Started Oct 2021
60 enrolled
Breakthrough Cancer Pain
Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain
Started Mar 2021
96 enrolled
Breakthrough Cancer Pain
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl
Started Jun 2019
41 enrolled
Healthy
Impact of CYP3A4*1G Polymorphism on Non-analgesic Effects of Fentanyl in Chinese Han Patients
Started Mar 2019
200 enrolled
Fentanyl
Loss of Exclusivity
LOE Date
Apr 27, 2030
50 months away
Patent Expiry
Apr 27, 2030